Carta científico-clínica
Rapamicina tópica al 0,2% para el tratamiento de angiofibromas faciales y máculas hipomelanóticas en la esclerosis tuberosa
Topical 0.2% Rapamycin to Treat Facial Angiofibromas and Hypomelanotic Macules in Tuberous Sclerosis
Leído
20858
Vecesse ha leído el artículo
4030
Total PDF
16828
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 86 | 14 | 100 |
| 2025 5 | 320 | 41 | 361 |
| 2025 4 | 351 | 26 | 377 |
| 2025 3 | 357 | 28 | 385 |
| 2025 2 | 311 | 46 | 357 |
| 2025 1 | 399 | 37 | 436 |
| 2024 12 | 268 | 25 | 293 |
| 2024 11 | 239 | 60 | 299 |
| 2024 10 | 291 | 48 | 339 |
| 2024 9 | 291 | 30 | 321 |
| 2024 8 | 236 | 70 | 306 |
| 2024 7 | 271 | 58 | 329 |
| 2024 6 | 290 | 45 | 335 |
| 2024 5 | 257 | 42 | 299 |
| 2024 4 | 241 | 29 | 270 |
| 2024 3 | 236 | 41 | 277 |
| 2024 2 | 377 | 41 | 418 |
| 2024 1 | 264 | 32 | 296 |
| 2023 12 | 196 | 26 | 222 |
| 2023 11 | 212 | 33 | 245 |
| 2023 10 | 203 | 17 | 220 |
| 2023 9 | 264 | 45 | 309 |
| 2023 8 | 308 | 29 | 337 |
| 2023 7 | 263 | 46 | 309 |
| 2023 6 | 275 | 31 | 306 |
| 2023 5 | 324 | 32 | 356 |
| 2023 4 | 294 | 30 | 324 |
| 2023 3 | 306 | 42 | 348 |
| 2023 2 | 286 | 36 | 322 |
| 2022 1 | 194 | 41 | 235 |
| 2022 12 | 212 | 41 | 253 |
| 2022 11 | 254 | 49 | 303 |
| 2022 10 | 311 | 48 | 359 |
| 2022 9 | 254 | 66 | 320 |
| 2022 8 | 275 | 59 | 334 |
| 2022 7 | 289 | 50 | 339 |
| 2022 6 | 231 | 34 | 265 |
| 2022 5 | 383 | 43 | 426 |
| 2022 4 | 258 | 35 | 293 |
| 2022 3 | 297 | 57 | 354 |
| 2022 2 | 237 | 29 | 266 |
| 2021 1 | 270 | 44 | 314 |
| 2021 12 | 243 | 36 | 279 |
| 2021 11 | 252 | 52 | 304 |
| 2021 10 | 293 | 75 | 368 |
| 2021 9 | 300 | 58 | 358 |
| 2021 8 | 222 | 37 | 259 |
| 2021 7 | 182 | 42 | 224 |
| 2021 6 | 386 | 59 | 445 |
| 2021 5 | 178 | 29 | 207 |
| 2021 4 | 349 | 54 | 403 |
| 2021 3 | 173 | 49 | 222 |
| 2021 2 | 115 | 32 | 147 |
| 2020 1 | 95 | 39 | 134 |
| 2020 12 | 93 | 23 | 116 |
| 2020 11 | 104 | 25 | 129 |
| 2020 10 | 117 | 24 | 141 |
| 2020 9 | 80 | 14 | 94 |
| 2020 8 | 129 | 25 | 154 |
| 2020 7 | 98 | 17 | 115 |
| 2020 6 | 102 | 24 | 126 |
| 2020 5 | 95 | 37 | 132 |
| 2020 4 | 71 | 22 | 93 |
| 2020 3 | 110 | 17 | 127 |
| 2020 2 | 8 | 3 | 11 |
| 2020 1 | 8 | 3 | 11 |
| 2019 12 | 2 | 6 | 8 |
| 2019 11 | 12 | 6 | 18 |
| 2019 10 | 5 | 5 | 10 |
| 2019 9 | 14 | 16 | 30 |
| 2019 8 | 1 | 7 | 8 |
| 2019 7 | 3 | 7 | 10 |
| 2019 6 | 2 | 50 | 52 |
| 2019 5 | 3 | 170 | 173 |
| 2019 4 | 10 | 53 | 63 |
| 2019 3 | 3 | 28 | 31 |
| 2019 2 | 17 | 20 | 37 |
| 2019 1 | 9 | 17 | 26 |
| 2018 12 | 10 | 10 | 20 |
| 2018 11 | 13 | 4 | 17 |
| 2018 10 | 24 | 2 | 26 |
| 2018 9 | 9 | 8 | 17 |
| 2018 8 | 2 | 25 | 27 |
| 2018 7 | 2 | 16 | 18 |
| 2018 6 | 0 | 14 | 14 |
| 2018 5 | 5 | 23 | 28 |
| 2018 4 | 2 | 11 | 13 |
| 2018 3 | 5 | 16 | 21 |
| 2018 2 | 58 | 16 | 74 |
| 2018 1 | 75 | 17 | 92 |
| 2017 12 | 59 | 23 | 82 |
| 2017 11 | 47 | 29 | 76 |
| 2017 10 | 70 | 27 | 97 |
| 2017 9 | 67 | 34 | 101 |
| 2017 8 | 61 | 41 | 102 |
| 2017 7 | 54 | 29 | 83 |
| 2017 6 | 69 | 47 | 116 |
| 2017 5 | 62 | 31 | 93 |
| 2017 4 | 73 | 52 | 125 |
| 2017 3 | 54 | 57 | 111 |
| 2017 2 | 48 | 72 | 120 |
| 2016 1 | 80 | 43 | 123 |
| 2016 12 | 65 | 43 | 108 |
| 2016 11 | 80 | 44 | 124 |
| 2016 10 | 92 | 75 | 167 |
| 2016 9 | 5 | 96 | 101 |
| 2016 8 | 1 | 64 | 65 |
| 2016 7 | 2 | 11 | 13 |
| 2016 6 | 4 | 1 | 5 |
| 2016 5 | 8 | 38 | 46 |
| 2016 4 | 4 | 3 | 7 |
| 2016 3 | 3 | 1 | 4 |
| 2016 2 | 9 | 1 | 10 |
| 2015 1 | 3 | 1 | 4 |
| 2015 12 | 4 | 14 | 18 |
| 2015 11 | 6 | 3 | 9 |
| 2015 10 | 3 | 2 | 5 |
| 2015 9 | 11 | 1 | 12 |
| 2015 8 | 5 | 1 | 6 |
| 2015 7 | 26 | 10 | 36 |
| 2015 6 | 22 | 6 | 28 |
| 2015 5 | 37 | 14 | 51 |
| 2015 4 | 20 | 15 | 35 |
| 2015 3 | 18 | 18 | 36 |
| 2015 2 | 14 | 10 | 24 |
| 2015 1 | 24 | 13 | 37 |
| 2014 12 | 8 | 8 | 16 |
| 2014 11 | 12 | 4 | 16 |
| 2014 10 | 28 | 29 | 57 |
Mostrar todo
